Minimal acute toxicity from proton beam therapy for major salivary gland cancer

References

• Sun EC, Curtis R, Melbye M, et al. Salivary gland cancer in the United States. Cancer Epidemiol Biomarkers Prev. 1999;8(12):1095–1100.
   PubMed Web of Science ®Google Scholar
• Orlandi E, Iacovelli NA, Bonora M, et al. Salivary gland. Photon beam and particle radiotherapy: present and future. Oral Oncol. 2016;60:146–156.
   PubMed Web of Science ®Google Scholar
• Adelstein DJ, Koyfman SA, El-Naggar AK, et al. Biology and management of salivary gland cancers. Semin Radiat Oncol. 2012;22(3):245–253.
   PubMed Web of Science ®Google Scholar
• Park G, Lee SW. Postoperative radiotherapy for mucoepidermoid carcinoma of the major salivary glands: long-term results of a single-institution experience. Radiat Oncol J. 2018;36(4):317–324.
   PubMed Web of Science ®Google Scholar
• Mifsud MJ, Tanvetyanon T, McCaffrey JC, et al. Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomas. Head Neck. 2016;38(11):1628–1633.
   PubMed Web of Science ®Google Scholar
• Safdieh J, Givi B, Osborn V, et al. Impact of adjuvant radiotherapy for malignant salivary gland tumors. Otolaryngol Head Neck Surg. 2017;157(6):988–994.
   PubMed Web of Science ®Google Scholar
• Schoenfeld JD, Sher DJ, Norris CM, Jr, et al. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy. Int J Radiat Oncol Biol Phys. 2012;82(1):308–314.
   PubMed Web of Science ®Google Scholar
• Gebhardt BJ, Ohr JP, Ferris RL, et al. Concurrent chemoradiotherapy in the adjuvant treatment of high-risk primary salivary gland malignancies. Am J Clin Oncol. 2018;41(9):888–893.
   PubMed Web of Science ®Google Scholar
• Deshpande TS, Blanchard P, Wang L, et al. Radiation-related alterations of taste function in patients with head and neck cancer: a systematic review. Curr Treat Options Oncol. 2018;19(12):72.
   PubMed Web of Science ®Google Scholar
• Sapir E, Tao Y, Feng F, et al. Predictors of dysgeusia in patients with oropharyngeal cancer treated with chemotherapy and intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2016;96(2):354–361.
   PubMed Web of Science ®Google Scholar
• Owosho AA, Yom SK, Han Z, et al. Comparison of mean radiation dose and dosimetric distribution to tooth-bearing regions of the mandible associated with proton beam radiation therapy and intensity-modulated radiation therapy for ipsilateral head and neck tumor. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(5):566–571.
   PubMed Web of Science ®Google Scholar
• Stromberger C, Cozzi L, Budach V, et al. Unilateral and bilateral neck SIB for head and neck cancer patients: intensity-modulated proton therapy, tomotherapy, and RapidArc. Strahlenther Onkol. 2016;192(4):232–239.
   PubMed Web of Science ®Google Scholar
• Romesser PB, Cahlon O, Scher E, et al. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. Radiother Oncol. 2016;118(2):286–292.
   PubMed Web of Science ®Google Scholar
• Grant SR, Grosshans DR, Bilton SD, et al. Proton versus conventional radiotherapy for pediatric salivary gland tumors: acute toxicity and dosimetric characteristics. Radiother Oncol. 2015;116(2):309–315.
   PubMed Web of Science ®Google Scholar
• Kocak-Uzel E, Gunn GB, Colen RR, et al. Beam path toxicity in candidate organs-at-risk: assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy. Radiother Oncol. 2014;111(2):281–288.
   PubMed Web of Science ®Google Scholar
• Ciura K, McBurney M, Nguyen B, et al. Effect of brain stem and dorsal vagus complex dosimetry on nausea and vomiting in head and neck intensity-modulated radiation therapy. Med Dosim. 2011;36(1):41–45. Spring
   PubMed Web of Science ®Google Scholar
• Lee VH, Ng SC, Leung TW, et al. Dosimetric predictors of radiation-induced acute nausea and vomiting in IMRT for nasopharyngeal cancer. Int J Radiat Oncol Biol Phys. 2012;84(1):176–182.
   PubMed Web of Science ®Google Scholar
• Monroe AT, Reddy SC, Gibbs GL, et al. Factors associated with radiation-induced nausea and vomiting in head and neck cancer patients treated with intensity modulated radiation therapy. Radiother Oncol. 2008;87(2):188–194.
   PubMed Web of Science ®Google Scholar
• Rosenthal DI, Chambers MS, Fuller CD, et al. Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;72(3):747–755.
   PubMed Web of Science ®Google Scholar
• Gulliford SL, Miah AB, Brennan S, et al. Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial. Radiother Oncol. 2012;104(2):205–212.
   PubMed Web of Science ®Google Scholar
• Group MDAHNCSW. Fatigue following radiation therapy in nasopharyngeal cancer survivors: a dosimetric analysis incorporating patient report and observer rating. Radiother Oncol. 2019;133:35–42.
   PubMed Web of Science ®Google Scholar
• Ferris MJ, Zhong J, Switchenko JM, et al. Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiation therapy. Radiother Oncol. 2018;126(1):100–106.
   PubMed Web of Science ®Google Scholar
• Rosenthal DI, Mendoza TR, Fuller CD, et al. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer. 2014;120(13):1975–1984.
   PubMed Web of Science ®Google Scholar
• Ahn PH, Lukens JN, Teo BK, et al. The use of proton therapy in the treatment of head and neck cancers. Cancer J. 2014;20(6):421–426.
   PubMed Web of Science ®Google Scholar